MedPath
Found 196 clinical trials|View Analysis
Sort by:
Need a comprehensive medical report on "HealthPartners Institute"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Phase 1
Completed
Conditions
Metastatic ER+ Breast Cancer
Interventions
First Posted Date
2017-06-28
Last Posted Date
2020-08-11
Lead Sponsor
TTC Oncology, LLC
Target Recruit Count
15
Registration Number
NCT03201913
Locations
🇺🇸

HealthPartners Institute, Regions Cancer Care Center, Saint Paul, Minnesota, United States

🇺🇸

HonorHealth Research Institute, Scottsdale, Arizona, United States

🇺🇸

University of Wisconsin, Carbone Cancer Center, Madison, Wisconsin, United States

and more 1 locations

Safety and Efficacy of DA-9805 for Parkinson's Disease

Phase 2
Completed
Conditions
Parkinson's Disease
Interventions
Drug: DA-9805 45mg
Drug: DA-9805 90mg
Other: Placebo
First Posted Date
2017-06-16
Last Posted Date
2022-05-24
Lead Sponsor
Dong-A ST Co., Ltd.
Target Recruit Count
61
Registration Number
NCT03189563
Locations
🇺🇸

HealthPartners Institute, Bloomington, Minnesota, United States

Microbiome Changes in Severe Burns

Completed
Conditions
Burns
Burns Greater Than 20% BSAB
First Posted Date
2017-04-27
Last Posted Date
2018-08-01
Lead Sponsor
HealthPartners Institute
Target Recruit Count
2
Registration Number
NCT03130868
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Patient Knowledge of Medication Indication

Completed
Conditions
Medical Audit
Interventions
Other: Medication knowledge
First Posted Date
2017-04-24
Last Posted Date
2018-06-07
Lead Sponsor
HealthPartners Institute
Target Recruit Count
40
Registration Number
NCT03125278
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Attain Stability™ Quad Clinical Study

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Device: Attain Stability Quad Left Ventricular Pacing Lead
First Posted Date
2017-04-04
Last Posted Date
2020-01-09
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Target Recruit Count
471
Registration Number
NCT03099655
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

🇺🇸

Piedmont Heart Institute, Atlanta, Georgia, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

and more 47 locations

LiveWell: A Mobile Intervention for Bipolar Disorder

Not Applicable
Completed
Conditions
Bipolar Disorder
Bipolar I Disorder
Interventions
Other: Psychiatric management
Behavioral: Psychosocial treatment
Behavioral: LiveWell Program
First Posted Date
2017-03-23
Last Posted Date
2021-10-04
Lead Sponsor
Northwestern University
Target Recruit Count
205
Registration Number
NCT03088462
Locations
🇺🇸

HealthPartners Institute, Bloomington, Minnesota, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

Single-Stage Integra Reconstruction in Burns

Not Applicable
Terminated
Conditions
Thermal Burn
Interventions
Device: thin Integra® (125 cm2)
First Posted Date
2017-03-10
Last Posted Date
2023-03-14
Lead Sponsor
HealthPartners Institute
Target Recruit Count
2
Registration Number
NCT03077087
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Olanzapine for Acute Headaches

Phase 4
Completed
Conditions
Headache
Interventions
Drug: Standard of Care as per attending physician
Drug: 5mg rapidly dissolving olanzapine
First Posted Date
2017-02-28
Last Posted Date
2022-01-12
Lead Sponsor
HealthPartners Institute
Target Recruit Count
122
Registration Number
NCT03066622
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

Phase 4
Completed
Conditions
Acute Bleeding on Long-Term Anticoagulation Therapy
Hemorrhage
Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation
Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)
Interventions
Drug: 4-factor prothrombin complex concentrate (4FPCC)
First Posted Date
2017-02-24
Last Posted Date
2023-09-14
Lead Sponsor
HealthPartners Institute
Target Recruit Count
79
Registration Number
NCT03064035
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access

Not Applicable
Completed
Conditions
Difficult IV Access
Interventions
Procedure: peripheral IV access procedure
Procedure: Peripheral IJ access procedure
First Posted Date
2017-02-24
Last Posted Date
2018-09-07
Lead Sponsor
HealthPartners Institute
Target Recruit Count
29
Registration Number
NCT03063996
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath